Focused Report: Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT), Implications for Driving a Commercial Motor Vehicle (CMV)

摘要

The purpose of this focused report is to address several key questions posed by the FMCSA on the use of dual-functioning implantable cardioverter defibrillators (ICDs) and pacemaker devices. Specifically, this document summarizes: Current indications for the use of ICDs, specifically, dual-functioning ICD-pacemaker devices. National standards and guidelines for the use of these devices, as well as existing recommendations on driving. Medicare coverage policies (i.e., for whom and under what circumstances). FDA-approved devices and current indications. Implications for commercial drivers given current physical requirements defined and codified in regulation Section 391.41 of the Federal Motor Carrier Safety Regulations (FMCSRs).